| 产品详情 |
| Edit |   |
|---|
| Product Name | Lanreotide Acetate |
|---|
| Description | Lanreotide Acetate is a drug used in the control and prevention of glycemia and hypoglycemic brain damage without surgery in patients diagnosed with congenital hyperinsulinism. It improves outcomes in patients suffering from acromegalyresulting from invasive pituitary macroadenoma. |
|---|
| Size | 10mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 3-(2-Naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2→7)-disulfide L-Threoninamide Acetate; 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane, cyclic peptide deriv. Acetate; 2: PN: WO0006185 PAGE: 8 claimed protein Acetate; BIM 23014C Acetate; Somatulina Acetate; Somatuline Acetate; |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 164735 |
|---|
| Price | |
|---|
| Order / More Info | Lanreotide Acetate from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|